Keybank National Association OH Lowers Stock Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• Keybank National Association OH cut its stake in Healthpeak Properties by 42% in Q4, selling 87,212 shares and ending the period with 120,494 shares valued at about $1.94 million.
• Institutional ownership stands at 93.57%, with major increases from State Street (49.50M shares) and JPMorgan (28.24M shares), underscoring heavy institutional concentration in the stock.
• Healthpeak slightly beat quarterly EPS expectations ($0.47 vs. $0.45) and set FY2026 guidance of $1.700–$1.740; shares trade near $16.44, the consensus analyst rating is a Hold (average target $18.04), and the company announced a monthly dividend of $0.1017 (7.4% yield) with an ex-dividend date of June 15.

Keybank National Association OH reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 42.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 120,494 shares of the real estate investment trust's stock after selling 87,212 shares during the quarter. Keybank National Association OH's holdings in Healthpeak Properties were worth $1,938,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. State Street Corp grew its stake in shares of Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock valued at $947,889,000 after purchasing an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the last quarter. Cullen Capital Management LLC grew its stake in shares of Healthpeak Properties by 6.7% in the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust's stock valued at $195,960,000 after purchasing an additional 641,771 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Healthpeak Properties by 4.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust's stock valued at $195,873,000 after purchasing an additional 400,900 shares during the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Healthpeak Properties by 28.5% in the 3rd quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust's stock valued at $190,292,000 after purchasing an additional 2,206,222 shares during the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on DOC shares. Scotiabank upgraded Healthpeak Properties to a "hold" rating in a research note on Thursday, April 23rd. Robert W. Baird lowered their target price on Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating on the stock in a research note on Monday, April 6th. Citigroup lowered their target price on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research note on Wednesday, April 1st. Argus downgraded Healthpeak Properties from a "buy" rating to a "hold" rating in a research note on Thursday, February 5th. Finally, Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Saturday. Five analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $18.04.

Healthpeak Properties Trading Up 1.7%

Shares of DOC stock opened at $16.44 on Friday. The business's fifty day moving average price is $16.94 and its 200 day moving average price is $17.17. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $19.68. The firm has a market capitalization of $11.43 billion, a PE ratio of 164.42, a P/E/G ratio of 2.23 and a beta of 1.00. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same quarter in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties's quarterly revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.74 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 7.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's dividend payout ratio is currently 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.